PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Aug-2024 PureTech Appoints Michele Holcomb, PhD, to Board of Directors PureTech Health plc
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc
22-Aug-2024 Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications AccessWire
22-Aug-2024 Coulter Partners places industry veteran Dr. David Hung as Chair of T-Therapeutics Coulter Partners
22-Aug-2024 Moderna to Host Investor Event - R&D Day and Business Updates AccessWire
22-Aug-2024 Arrival of deadlier ‘clade I’ mpox in Europe highlights need for better testing and treatment: expert London Medical Laboratory
22-Aug-2024 Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Touchlight
22-Aug-2024 GermFree and Caring Cross partner to transform access to cellular gene therapies GermFree
22-Aug-2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development Vandria SA
22-Aug-2024 Breaking down barriers DeSci Labs
22-Aug-2024 Kelso Pharma appoints first Director of Corporate Development as international expansion continues Kelso Pharma
22-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
22-Aug-2024 London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building London BioScience Innovation Centre
22-Aug-2024 Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System AccessWire
22-Aug-2024 RedHill Announces Positive Obesity and Diabetes Results with Opaganib RedHill Biopharma
22-Aug-2024 Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project Cumulus Oncology
22-Aug-2024 Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor Adcendo ApS and Multitude Therapeutics Inc
22-Aug-2024 iOmx Therapeutics Initiates Phase Ib with OMX-0407 iOmx Therapeutics AG
22-Aug-2024 Bioz and Spirochrome Forge Partnership to Enhance Research Discovery With Advanced Scientific Video Content AccessWire
22-Aug-2024 Explore Next-Generation Sequencing (NGS) Technology Prophecy Market Insights